Welcome to our dedicated page for Aurora Cannabis Common Shares news (Ticker: ACB), a resource for investors and traders seeking the latest updates and insights on Aurora Cannabis Common Shares stock.
Aurora Cannabis Inc. (NASDAQ: ACB, TSX: ACB) is a prominent Canadian company headquartered in Edmonton, Alberta, dedicated to the cultivation, production, and sale of high-quality cannabis for both medical and recreational use. The company's state-of-the-art facilities in Alberta embody advanced cultivation techniques that ensure the highest standards of quality, reliability, and safety in their products. Aurora's comprehensive portfolio includes renowned brands like Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, catering to a wide range of consumer preferences.
Aurora's operations extend beyond Canada, with significant international presence through medical cannabis exporting agreements. A notable subsidiary, Australis Capital Inc., plays a crucial role in participating in the U.S. cannabis market. The company's commitment to quality is further highlighted by its EU-GMP and TGA-GMP certified production facilities, ensuring compliance with rigorous international standards.
In recent developments, Aurora has launched three new cannabis-infused beverages targeted initially at veteran patients. These products, featuring innovative SōRSE® emulsion technology, offer an alternative form of cannabis consumption without the strong cannabis aroma or taste. Available in flavors like Neon Rush, Strawberry Pineapple Tropical Fizz, and Pineapple Coconut Fizz, these beverages are designed to enhance patient wellbeing with a refreshing and potent experience.
Financially, Aurora has achieved significant milestones, including the repayment of nearly $465 million in convertible debt and forecasting positive free cash flow for calendar 2024. The company has also strengthened its global footprint by acquiring MedReleaf Australia's majority equity, further solidifying its position in the Australian market. Aurora’s commitment to financial discipline and strategic expansions underscores its potential for sustainable growth.
Aurora's dedication to innovation and patient care is exemplified through its continuous development of new products and partnerships. Their recent launches include resin cartridges and pastilles in Australia, expanding their product range and enhancing patient access to premium medical cannabis. Additionally, the company's strategic moves in Europe, particularly in Germany, position it as a leader in the evolving cannabis landscape.
With a robust pipeline of products and strategic market expansions, Aurora Cannabis Inc. continues to pave the way for significant advancements in the global cannabis industry, committed to improving lives through high-quality, innovative cannabis products.
High Tide Inc. has opened two new retail cannabis stores in Windsor and Cornwall, Ontario, increasing its total to 101 locations in Canada and 30 in Ontario. September has seen the launch of eight new stores, underlining the company's growth despite pandemic-related challenges. The Windsor store is strategically located in a commercial district, while the Cornwall outlet sits in a prominent retail plaza. To celebrate its 100-store milestone, High Tide will support World Vision by sponsoring two additional children for each new store. The company aims to exceed 200 locations nationally by 2022.
Aurora Cannabis has launched Bidiol, the first domestically produced medical cannabis oil in Uruguay, available in 3% and 10% concentrations. This launch is a key component of Aurora's renewed strategy focusing on the Uruguayan market, aiming to establish the country as a center for medical cannabis production. The oil is authorized for treating refractory epilepsy in children and adolescents and is available in pharmacies. Aurora plans to expand its CBD oil portfolio in Uruguay shortly.
Aurora Cannabis (ACB) reported a 9% increase in total medical cannabis net revenue year-over-year, reaching $35 million. The company achieved an adjusted gross margin of 68% and narrowed its adjusted EBITDA loss by $17.6 million to $13.9 million. However, total cannabis net revenue decreased to $54.8 million, a 19% decline compared to the previous year. Aurora maintains a robust cash position of $440.9 million and announced cost savings of $60 to $80 million through its business transformation plan. The company aims for adjusted EBITDA profitability in the near future.
High Tide Inc. has been recognized as one of Canada’s top growing companies for 2021 by the Globe and Mail, ranking 82nd out of 448 firms with a remarkable three-year revenue growth of 733%. This recognition highlights High Tide's operational success since its first cannabis retail store opened in October 2018, growing from 160 employees to nearly 100 stores and over 900 employees. The Company plans to enhance revenue through further retail and e-commerce expansion in Canada, the United States, and Europe.
Aurora Cannabis Inc. (ACB) has rescheduled its conference call to discuss the fourth quarter and full fiscal year 2021 results to Monday, September 27, 2021, at 5:00 p.m. ET. The financial results and related annual disclosure documents will be released after market close on the same day. CEO Miguel Martin and CFO Glen Ibbott will host the call, allowing investors to submit questions via a designated weblink. Aurora, headquartered in Edmonton, Alberta, is a leader in the cannabis industry, focusing on high-quality cannabis products.
High Tide Inc. has revealed its new cannabis retail concept, Cannabis Chop Club, aimed at value-focused consumers. The stores will be smaller, averaging 1,000-1,200 square feet, and have lower build costs of $125,000 to $150,000. The Chop Club will offer exclusive deals for members and leverage High Tide’s existing loyalty programs. CEO Raj Grover highlights the potential to capture market share from the illicit cannabis market. The company, known for its retail cannabis and consumption accessories, operates 93 locations in Canada.
Aurora Cannabis (NASDAQ: ACB; TSX: ACB) will discuss its fourth quarter and full fiscal year 2021 results on September 21, 2021, at 5:00 p.m. ET. The financial results will be released after market close on the same day. The call will be hosted by CEO Miguel Martin and CFO Glen Ibbott, allowing investors to submit questions through the provided web link. The company will also conduct its Annual General Meeting virtually on November 12, 2021, at 12:00 p.m. ET.
High Tide Inc. has successfully converted all outstanding META Convertible Debentures into common shares, significantly reducing its total debt from approximately $71 million to $28.4 million, with $10.8 million being non-interest bearing. The company reported that total debt maturities for the next 12 months are $1.6 million. This move is part of High Tide's strategy to strengthen its balance sheet while expanding its e-commerce presence in the U.S. market. CEO Raj Grover emphasized growth in revenues and cash reserves since acquiring META in November 2020.
Aurora Cannabis Inc. (ACB) announced the successful delivery of its initial shipment of medical cannabis to France's pilot program, in partnership with Ethypharm. This pivotal milestone emphasizes Aurora's role as a primary supplier, fulfilling obligations to provide premium cannabis products sourced from its EU GMP facility in Denmark. The pilot program, set to serve patients shortly, marks a significant step toward increasing access to medical cannabis in France and potentially developing a large regulated market across Europe.
Aurora Cannabis (ACB) announced the appointment of Theresa Firestone as a new independent director, expanding its Board to nine members, with seven being independent. Firestone brings over 20 years of experience in healthcare and pharmaceuticals, previously holding senior roles at Pfizer and the Ontario Ministry of Health. Her extensive expertise in strategic planning and business development is expected to enhance Aurora's strategic growth plans while managing costs. Chairman Ronald Funk expressed confidence in her ability to contribute significantly to the company.
FAQ
What is the current stock price of Aurora Cannabis Common Shares (ACB)?
What is the market cap of Aurora Cannabis Common Shares (ACB)?
What is Aurora Cannabis Inc. primarily known for?
Where is Aurora Cannabis Inc. headquartered?
What are some of the brands under Aurora Cannabis?
What recent products has Aurora Cannabis launched?
What is Aurora's financial outlook for 2024?
What significant acquisitions has Aurora made recently?
What certifications do Aurora's production facilities hold?
How does Aurora contribute to the U.S. cannabis market?
What international operations does Aurora have?
How does Aurora ensure the quality of its products?
